Download PDF
1
/
Pages
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Glycemic control, the unconsidered outcome in the treatment of nonalcoholic fatty liver disease
Diego García-Compeán; Emanuela Orsi; Tsutomu Nishida; Ramesh Kumar;
10.1016/j.aohep.2021.100648
The Janus of a disease: Diabetes and metabolic dysfunction-associated fatty liver disease
Francisco Barrera; Javier Uribe; Nixa Olvares; Paula Huerta; Daniel Cabrera; Manuel Romero-Gómez;
Ann Hepatol. 2024;29:
Prevalence of liver fibrosis in an unselected general population with high prevalence of obesity and diabetes mellitus. Time for screening?
Diego García-Compeán; Jesús Zacarías Villarreal-Pérez; Manuel Enrique de la O. Cavazos; Fernando Javier Lavalle-Gonzalez; Omar David Borjas-Almaguer; Angel Noé Del Cueto-Aguilera; José Alberto González-González; Consuelo Treviño-Garza; Lourdes Huerta-Pérez; Héctor Jesús Maldonado-Garza;
Ann Hepatol. 2020;19:258-64